{
  "nctId": "NCT02872311",
  "briefTitle": "Open-Label Influenza Vaccine Evaluation",
  "officialTitle": "Open-Label, Randomized Study of Immune Response to Licensed Influenza Vaccines in Adults 65-74 Years of Age (US Flu Vaccine Effectiveness Serologic Study, 2016-17 and 2017-18)",
  "protocolDocument": {
    "nctId": "NCT02872311",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2017-07-15",
    "uploadDate": "2019-03-13T17:12",
    "size": 580551,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02872311/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 179,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-09",
    "completionDate": "2018-09",
    "primaryCompletionDate": "2018-04",
    "firstSubmitDate": "2016-08-16",
    "firstPostDate": "2016-08-19"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Age 65-74 years at the time of study enrollment and are ambulatory and live in selected Wisconsin community or surrounding communities.\n* Willing and able to give informed consent prior to study enrollment\n* Able to comply with study requirements.\n\nExclusion Criteria:\n\n* Prior receipt of 2016-17 influenza vaccine\n* Current participation in another clinical trial\n* Presence of a contraindication to influenza vaccine",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "65 Years",
    "maximumAge": "74 Years",
    "stdAges": [
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "HI Titers, HD vs. AD, Yr 1 Day 28 Post Vaccination",
        "description": "Hemagglutination Inhibition (HI) titers to vaccine viruses for high dose and adjuvanted vaccine recipients at 28 days post vaccination 2016-17",
        "timeFrame": "Year 1, Day 28 post vaccination"
      },
      {
        "measure": "HI Titers, HD vs. AD, Yr 1 Day 182 Post Vaccination",
        "description": "Hemagglutination Inhibition (HI) titers to vaccine viruses for high dose and adjuvanted vaccine recipients at 182 days post vaccination 2016-17",
        "timeFrame": "Year 1, Day 182 post vaccination"
      },
      {
        "measure": "HI Titers, HD vs. AD, Yr 1 Day 365 Post Vaccination",
        "description": "Hemagglutination Inhibition (HI) titers to vaccine viruses for high dose and adjuvanted vaccine recipients at 365 days post vaccination 2016-17",
        "timeFrame": "Year 1, Day 365 post vaccination"
      },
      {
        "measure": "HI Titers, HD vs. AD, Yr 2 Day 28 Post Vaccination",
        "description": "Hemagglutination Inhibition (HI) titers to vaccine viruses for high dose and adjuvanted vaccine recipients at 28 days post vaccination 2017-18",
        "timeFrame": "Year 2, Day 28 post vaccination"
      },
      {
        "measure": "HI Titers, HD vs. AD, Yr 2 Day 182 Post Vaccination",
        "description": "Hemagglutination Inhibition (HI) titers to vaccine viruses for high dose and adjuvanted vaccine recipients at 182 days post vaccination 2017-18",
        "timeFrame": "Year 2, Day 182 post vaccination"
      }
    ],
    "secondary": [
      {
        "measure": "HI Response by Prior Season Vaccination, Yr 1, Day 28 Post Vaccination",
        "description": "Hemagglutination inhibition (HI) Titers by prior season (2015-16) vaccination status among adjuvant and high dose vaccine recipients 28 days post vaccination, 2016-17",
        "timeFrame": "Year 1, Day 28 post vaccination"
      },
      {
        "measure": "HI Response by Prior Season Vaccination, Yr 1, Day 182 Post Vaccination",
        "description": "Hemagglutination inhibition (HI) Titers by prior season (2015-16) vaccination status among adjuvant and high dose vaccine recipients 182 days post vaccination, 2016-17",
        "timeFrame": "Year 1, Day 182 post vaccination"
      },
      {
        "measure": "HI Response by Prior Season Vaccination, Yr 1, Day 365 Post Vaccination",
        "description": "Hemagglutination inhibition (HI) Titers by prior season (2015-16) vaccination status among adjuvant and high dose vaccine recipients 365 days post vaccination, 2016-17",
        "timeFrame": "Year 1, Day 365 post vaccination"
      },
      {
        "measure": "MN Titers, HD vs. AD, Year 1, Day 28 Post Vaccination",
        "description": "Microneutralization antibody titers to vaccine and drifted viruses among high dose and adjuvanted vaccine recipients 28 days post vaccination, 2016-17",
        "timeFrame": "Year 1, Day 28 post vaccination"
      },
      {
        "measure": "MN Titers, HD vs. AD, Year 1, Day 182 Post Vaccination",
        "description": "Microneutralization antibody titers to vaccine and drifted viruses among high dose and adjuvanted vaccine recipients 182 days post vaccination, 2016-17",
        "timeFrame": "Year 1, Day 182 post vaccination"
      },
      {
        "measure": "MN Titers, HD vs. AD, Year 1, Day 365 Post Vaccination",
        "description": "Microneutralization antibody titers to vaccine and drifted viruses among high dose and adjuvanted vaccine recipients 365 days post vaccination, 2016-17",
        "timeFrame": "Year 1, Day 365 post vaccination"
      },
      {
        "measure": "MN Titers (A/Hong Kong (Siat Cell)), HD vs. AD, Year 2, Day 28 Post Vaccination",
        "description": "Microneutralization antibody titers to vaccine virus (A/Hong Kong (siat cell) among high dose and adjuvanted vaccine recipients 28 days post vaccination, 2017-18",
        "timeFrame": "Year 2, Day 28 post vaccination"
      },
      {
        "measure": "HI Titers, HD vs. AD vs. RIV With Prior Season Standard (IIV) Dose, Year 2, Day 28 Post Vaccination",
        "description": "Hemagglutination Inhibition (HI) titers to vaccine viruses among adjuvant, high dose and recombinant recipients with prior season standard dose vaccine at 28 days post vaccination 2017-18",
        "timeFrame": "Year 2, Day 28 post vaccination"
      },
      {
        "measure": "HI Titers, HD vs. AD vs. RIV With Prior Season Standard (IIV) Dose, Year 2, Day 182 Post Vaccination",
        "description": "Hemagglutination Inhibition (HI) titers to vaccine viruses among adjuvant, high dose and recombinant recipients with prior season standard dose vaccine at 182 days post vaccination 2017-18",
        "timeFrame": "Year 2, Day 182 post vaccination"
      },
      {
        "measure": "HI Titers, IIV+AD or HD vs. Sequential AD or HD, Year 2, Day 28 Post Vaccination",
        "description": "Hemagglutination inhibition (HI) titers among HD and AD based on prior season vaccination (standard or sequential same vaccination) at 28 days after vaccination, 2017-18",
        "timeFrame": "Year 2, Day 28 post vaccination"
      },
      {
        "measure": "HI Titers, IIV+AD or HD vs. Sequential AD or HD, Year 2, Day 182 Post Vaccination",
        "description": "Hemagglutination inhibition (HI) titers among HD and AD based on prior season vaccination (standard or sequential same vaccination) at 182 days after vaccination, 2017-18",
        "timeFrame": "Year 2, Day 182 post vaccination"
      },
      {
        "measure": "Number of Participants With Vaccine Failure, Year 1",
        "description": "Number of Participants with Vaccine Failure in Year 1 by vaccine type",
        "timeFrame": "Year 1, Post season"
      },
      {
        "measure": "Number of Participants With Vaccine Failure, Year 2",
        "description": "Number of Participants with Vaccine Failure in Year 2 by two-year vaccine history",
        "timeFrame": "Year 2, Post season"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 5,
      "secondaryCount": 13,
      "otherCount": 0,
      "totalCount": 18
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:30:34.702Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}